Zobrazeno 1 - 7
of 7
pro vyhledávání: '"P J de Vos van Steenwijk"'
Autor:
Natasja Hendriks, Sjoerd H van der Burg, Ziena Abdulrahman, Noel F C C de Miranda, Edith M G van Esch, Peggy J de Vos van Steenwijk, Antonios Somarakis, Arnold J Kruse, Anna J M van de Sande, Heleen J van Beekhuizen, Jurgen M J Piek, Loes F S Kooreman, Brigitte F M Slangen
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 11 (2022)
Background The complete response rate of cervical high-grade squamous intraepithelial lesion (cHSIL) patients to imiquimod immunotherapy is approximately 60%. Consequently, many patients are exposed to unnecessary adverse effects of imiquimod. On the
Externí odkaz:
https://doaj.org/article/ae2985823b1043c281f9a4695715eadb
Autor:
Hans Gelderblom, Sjoerd H van der Burg, Ferry Ossendorp, Peggy J de Vos van Steenwijk, Mariette I E van Poelgeest, Inge Roozen, Willem-Jan Krebber, Cornelis J M Melief, Frank M Speetjens, Marij J P Welters, Nikki M Loof, Sanne Boekestijn, Catharina A H Janssen, Marije Slingerland, Gijs G Zom, A Rob P M Valentijn, Nico J Meeuwenoord, Gijs A van der Marel, Dmitri V Filippov
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 10 (2022)
Background Amplivant is a molecularly optimized Toll-like receptor 2 ligand that can be covalently conjugated to tumor peptide antigens. In preclinical models, amplivant-adjuvanted synthetic long peptides (SLPs) strongly enhanced antigen presentation
Externí odkaz:
https://doaj.org/article/116d0102ba984134b3b45409c8b1b84b
Autor:
Sjoerd H van der Burg, Ziena Abdulrahman, Noel de Miranda, Edith M G van Esch, Peggy J de Vos van Steenwijk, Hans W Nijman, Marij J. P. Welters, Mariette I E van Poelgeest
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Background Vulvar high-grade squamous intraepithelial lesion (vHSIL) is predominantly induced by high-risk human papilloma virus type 16 (HPV16). In two independent trials, therapeutic vaccination against the HPV16 E6 and E7 oncoproteins resulted in
Externí odkaz:
https://doaj.org/article/0e0d2f0ef1a04f048f971b6ef0646463
Publikováno v:
Cancer Immunology, Immunotherapy. 70:1821-1829
Introduction Endometriosis is a risk factor for low-grade serous, clear cell, and endometroid ovarian carcinoma. In both endometriosis and ovarian carcinoma, immunological factors are associated with clinical outcome. Chronic inflammation in endometr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0d285de2f2475e23007461becf20edc
https://doi.org/10.1007/s00262-020-02831-1
https://doi.org/10.1007/s00262-020-02831-1
Publikováno v:
Cancer immunology, immunotherapy : CII. 70(7)
Endometriosis is a risk factor for low-grade serous, clear cell, and endometroid ovarian carcinoma. In both endometriosis and ovarian carcinoma, immunological factors are associated with clinical outcome. Chronic inflammation in endometriosis may be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e94fe7ee293bfece4dd0b599bcb8cd84
https://pubmed.ncbi.nlm.nih.gov/33411080
https://pubmed.ncbi.nlm.nih.gov/33411080
Autor:
M. van 't Riet, Johannes Jeekel, Hendrik J. Bonjer, P. J. de Vos van Steenwijk, Ewout W. Steyerberg
Publikováno v:
Hernia, 11(5), 409-413. Springer Paris
In patients with postoperative wound dehiscence in the presence of infection, extensive visceral oedema often necessitates mechanical containment of bowel. Prosthetic mesh is often used for this purpose. The aim of the present study was to assess the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec7850bad76d6ee83c9619b3398b2340
https://pure.eur.nl/en/publications/a543610c-e6fa-4995-b182-bbd4c2744a3c
https://pure.eur.nl/en/publications/a543610c-e6fa-4995-b182-bbd4c2744a3c
Autor:
P J, de Vos van Steenwijk, T H, Ramwadhdoebe, R, Goedemans, E M, Doorduijn, J J, van Ham, A, Gorter, T, van Hall, M L, Kuijjer, M I E, van Poelgeest, S H, van der Burg, E S, Jordanova
Publikováno v:
International journal of cancer. 133(12)
One of the hallmarks of cancer is the influx of myeloid cells. In our study, we investigated the constitution of tumor-infiltrating myeloid cells and their relationship to other tumor-infiltrating immune cells, tumor characteristics and the disease-s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a392d9d3c27ebf270c6e3e37387d5c77
https://pubmed.ncbi.nlm.nih.gov/23740735
https://pubmed.ncbi.nlm.nih.gov/23740735